Moderna Allocates $3 Million to Progress mRNA Therapeutics in Australia

Australia's Monash University and American firm Moderna have announced the establishment of the Monash-Moderna Quantitative Pharmacology Accelerator (MMQPA...

August 18, 2023 | Friday | News
Sartorius & Repligen Launch Integrated Bioprocessing System for Process Intensification

Bioreactor and cell retention technology integration features a single direct control interface to simplify intensified seed train implementation. Custo...

August 18, 2023 | Friday | News
Agilent's President Mike McMullen Applauds Strong Performance Despite Economic Challenges, Expresses Confidence in Long-Term Growth

Highlights: Reported revenue of $1.67 billion declined 2.7% year-over-year, and decreased 2.3% on a core(1) basis. GAAP net income of $111 millio...

August 18, 2023 | Friday | Company results
Novartis Completes Acquisition of Chinook Therapeutics

Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for USD 3.2bn upfront Deal brings two phase 3 assets in d...

August 14, 2023 | Monday | News
Thermo Fisher to Coordinate Transplant Stats for US NIH

T-SCCC will support initiatives seeking to ensure success of organ transplants for patients The PPD clinical research business of Thermo Fisher Scientific...

August 11, 2023 | Friday | News
"Illumina Reports 8% Sequential Revenue Growth in Q2, NovaSeq X Shipments Exceed Expectations," says Interim CEO Charles Dadswell

Revenue of $1.18 billion for Q2 2023, up 1% from Q2 2022 (up 3% on a constant currency basis) and up 8% from Q1 2023 Shipped 109 NovaSeq X instruments i...

August 10, 2023 | Thursday | Company results
Oncolytics Biotech® Raises $15M to Advance Cancer Clinical Programs

Leede Jones Gable Inc. acted as underwriter and bookrunner (the "Underwriter") in accordance with the terms of an underwriting agreement between the Compan...

August 09, 2023 | Wednesday | News
Verista and Sware Partner to Revolutionize Digital Validation in Life Sciences

By incorporating Sware's Res_Q platform, clients can enhance, streamline, and optimize the flow of content and data, effectively addressing the challenges ...

August 09, 2023 | Wednesday | News
FDA Approves QIAGEN's Companion Diagnostic for AYVAKIT® in Gastrointestinal Stromal Tumors

QIAGEN announced the U.S. Food and Drug Administration (FDA) approval of its therascreen PDGFRA RGQ PCR kit (therascreen PDGFRA kit). This companion diagn...

August 08, 2023 | Tuesday | News
Merck's CEO Belén Garijo Optimistic About 2023 as Healthcare Business Drives Growth

Financial results of Q2 2023 Net sales decrease organically by −1.1% to € 5.3 billion EBITDA pre down organically by −7.0% t...

August 08, 2023 | Tuesday | Company results
Agilent Announces Thought Leader Award to Peter Neubauer

-Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award. As Chair of...

August 07, 2023 | Monday | News
Gilead's Remarkable Q2 Performance: 11% Year-Over-Year Growth Fueled by Diverse Therapeutic Portfolio, Positive Regulatory Advances, and Promising Pipeline, Declares CEO Daniel O’Day

Product Sales Excluding Veklury Increased 11% Year-Over-Year to $6.3 billion Biktarvy Sales Increased 17% Year-Over-Year to $3.0 billion Oncology Sales...

August 07, 2023 | Monday | Company results
Bavarian Nordic's Chikungunya Vaccine Shows Positive Phase 3 Results in Adults and Adolescents

Chikungunya vaccine candidate met all the co-primary endpoints of the Phase 3 study and was shown to be highly immunogenic in the majority of subjects 22...

August 07, 2023 | Monday | News
Bio-Rad's CEO Norman Schwartz Confident Despite Lowered 2023 Expectations Due to Shifting Biotech Market Dynamics

Second-quarter 2023 net sales were $681.1 million, a decrease of 1.4 percent compared to $691.1 million reported for the second quarter of 2022. On a curre...

August 04, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close